Walleye Capital’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-30,733
Closed -$132K 2320
2021
Q4
$132K Sell
30,733
-230
-0.7% -$1.24K ﹤0.01% 1600
2021
Q3
$185 Buy
30,963
+20,790
+204% +$139K 0.01% 1205
2021
Q2
$84 Sell
10,173
-157,667
-94% -$1.28M ﹤0.01% 1184
2021
Q1
$1.44K Buy
+167,840
New +$1.86M 0.08% 205

Other funds holding CGEN

Walleye Capital's CGEN Position: Q1 2022 in Review

Walleye Capital sold out of Compugen (CGEN) in Q1 2022, closing a stake of 30,733 shares — an estimated $132K sold.

Walleye Capital first reported a position in CGEN in Q1 2021 and held it in 4 quarters. The position peaked at $132K in Q4 2021. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.

  • Walleye Capital reported no remaining Compugen position as of Q1 2022 after selling out during the quarter.
  • Walleye Capital sold 30,733 Compugen shares in Q1 2022, an estimated $132K.
  • Walleye Capital first reported a position in Compugen in Q1 2021 and held it in 4 quarters.
  • Walleye Capital's Compugen position peaked at $132K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.